Oncolytics Biotech (TSE:ONC) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Oncolytics Biotech Inc., a leader in immunotherapy for cancer treatment, is set to discuss its first quarter financial outcomes and recent operational milestones in a conference call and webcast on May 9, 2024. Investors and stakeholders can access the event live or through a replay for insights into the company’s progress, particularly regarding pelareorep, their promising immunotherapeutic agent in clinical trials for various cancers.
For further insights into TSE:ONC stock, check out TipRanks’ Stock Analysis page.
